Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
Tagshealthcare Health Care patent agriculture business development renewable fuel standard Events BIO International Convention FDA Biofuel Technology BIO Events BIOTECH One-on-One's Partnering health public policy biofuel Greenhouse Gas Emission climate change biotech industry
- Most Popular
Latest VideoHans Schikan, CEO of Prosensa, on Rare Disease Drug Development View All >